Alovudine F-18 is under investigation in clinical trial NCT02819024. Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography. Reference standards of Alovudine 18F Injection API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Alovudine (18F) Injection
Catalogue No.:PA 01 4010000
CAS :
Molecular Formula : C10H1318FN2O4
Molecular Weight : 243.22
tert-Butyl 3-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-[[(4-nitrophenyl)sulfonyl]oxy]tetrahydrofuran-2-yl]-5-methyl-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-carboxylate
Catalogue No.:PA 01 4010050
Molecular Formula : C42H43N3O13S
Molecular Weight : 829.87
(2R,3R,5R)-3-[[Bis(4-methoxyphenyl)phenylmethoxy]-methyl]-8-methyl-2,3-dihydro-9H-2,5-methanopyrimido-[2,1-b][1,5,3]dioxazepin-9-one
Catalogue No.:PA 01 4010060
Molecular Formula : C31H30N2O6
Molecular Weight : 526.59
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
